Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

News & Events
: Investor Presentations

Investor Presentations

Investor Presentation - Long Version

Uploaded: Aug 21, 2019
Type: Pdf

Investor Presentation - Abbreviated Version

Uploaded: Aug 21, 2019
Type: Pdf